CVE-2018-14789 — In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privi

01What is this vulnerability?

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.

02Affected products

Vendor	Product	Versions
Philips	IntelliSpace Cardiovascular (ISCV) products	IntelliSpace Cardiovascular, Version 3.1 or prior, Xcelera Version 4.1 or prior

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

• Patch to a fixed version listed in the vendor advisory (see references below).
• Mitigate with WAF rules, network egress filters, or feature flags where the patch is not yet available.
• Hunt historical logs for exploitation indicators — see Detection signatures below.

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

• Published: 2018-08-22T18:00:00.000Z
• Last modified: 2024-09-16T17:18:12.900Z

09References

• www.usa.philips.com — https://www.usa.philips.com/healthcare/about/customer-support/product-security
• ics-cert.us-cert.gov — https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01